Clinical Trial Update: A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for AND017 in treating anemia in non-dialysis-dependent chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease with Anemia
• Renal Anemia

Drugs mentioned

• AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Renal Anemia | Phase 2 | Status: COMPLETED